DRIVIN G ROWTH - Dr. Reddy's

264
special report on the accounts
FOR THE PERIOD ENDING MARCH 31, 2002
Dear Shareholders,
In our capacity as the Statutory Auditors of your Company, we hereby present our report on regulated agreements.
Under Article L 225-40 of the new commercial code, we have been informed about a new agreement signed during the period after
authorisation.
It is not our responsibility to look for other agreements that may exist or to pass judgement on whether any agreements are useful or
worthwhile, but to inform you, based on the information provided us, of the basic features and details of those agreements of which
we have been notified. It is up to you, based on the terms of Article 92 of the Decree of 23 March 1967, to assess whether it is in
your interest to enter into these agreements before approving them.
Our due diligence consisted of ensuring, in accordance with current professional standards in France, that the information we have
been given is consistent with the documents on which it is based.
A list of the Directors affected by these agreements is given on the last page.
NEW AGREEMENT SIGNED DURING THE PERIOD AFTER AUTHORISATION
Authorisation
Supervisory board meeting of April 2, 2001
Nature of the agreement
Payment on behalf of the Dr REDDY’S LABORATORIES LTD.
Terms
Your Company has paid Euro 51,917 on behalf of Dr. REDDY’S LABORATORIES LTD for the purchase of the company MERIDIAN.
A debit note will be issued.
Moreover, under the Decree of March 23, 1967, we have been notified that the following agreements that had been approved during
previous financial years have remained in effect even during the current financial year.
AGREEMENTS REACHED IN PREVIOUS YEARS THAT HAVE REMAINED IN EFFECT THIS YEAR
A – Agreement with Qualifarma
AGREEMENT 1
Authorisation
Supervisory Board meeting of April 9, 1999.
Nature of the agreement
Invoicing Qualifarma for commissions on commercial services for Qualifarma and fees for administrative and commercial services.
Terms
Your Company billed the amount of EUR 2,534,703 for commissions and services for the year.
AGREEMENT 2
Authorisation
Supervisory Board meeting of April 9, 1999.
Nature of the agreement
Rebilling travel expenses incurred by your Company on behalf of Qualifarma
Terms
Nothing was invoiced during the year.
REDDY CHEMINOR S.A. | FINANCIALS | ANNUAL REPORT 2001-2002